Background: Anti-Sry-like high mobility group box 1 (anti SOX-1) proteins are rare onconeural antibodies associated with paraneoplastic Lambert-Eaton myasthenic syndrome (LEMS). Few patients with anti-SOX-1 antibodies and negative anti-glial nuclear antibody reactivity have been described to date.

Case Subject And Methods: Our case involves a 72-year-old female patient with progressive girdle weakness, sensation of heaviness in the lower limbs, predominantly distal and associated with circulatory problems together with instability when walking, with a high suspicion of an autoimmune myopathic disorder. Immunoblot test for autoimmune myopathies antibodies detection were all negative. Onconeuronal antibodies were determined in serum by indirect immunofluorescence being negative as well. Given the high suspicion, we also checked for the presence of other antineuronal antibodies whose patterns are not visible by IIF.

Results: Onconeuronal antibodies by immunoblot for the following antibodies: Hu, Ri, Yo, Zic4, Tr, PCA-2, MA-TA, CV2, GAD65, Zic4, Titin, SOX1, Recoverin and Amp, revealed an unexpected clear band in SOX-1, which are highly suggestive of paraneoplastic LEMS.

Discussion: We hypothesize that discordant onconeuronal antibodies results were due to the fact that positivity in IIF is associated with other SOX-B group proteins (normally related to cases of non-paraneoplastic neuropathy), while negativity in IIF and subsequent confirmed presence of specific SOX1 antibody by immunoblot could indicate an underlying tumor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2021.08.004DOI Listing

Publication Analysis

Top Keywords

onconeuronal antibodies
12
antibodies
9
paraneoplastic lambert-eaton
8
high suspicion
8
discordant sox-1
4
sox-1 antibodies
4
antibodies paraneoplastic
4
lambert-eaton syndrome
4
syndrome diagnosis
4
diagnosis clinical
4

Similar Publications

Article Synopsis
  • Chronic lymphoproliferative disorder of natural killer cells (CLPD-NK) is a rare disease with high NK cell counts that is often asymptomatic, but can lead to symptoms like fatigue, fever, and autoimmune diseases.
  • A 61-year-old male patient diagnosed with CLPD-NK experienced numbness and elevated protein levels in cerebrospinal fluid, indicating potential immunological issues, which were treated with steroids and immunoglobulin therapy.
  • Despite treatment alleviating some symptoms, the patient developed significant autonomic dysfunction, leading to issues like diarrhea and orthostatic hypotension, while tests for specific antibodies were negative, and a nerve biopsy suggested lymphocytic infiltration.
View Article and Find Full Text PDF

Introduction: Anti-neuronal antibodies target antigens produced by tumour cells and cells of nervous system. These antibodies are formed as a result of autoimmune response elicited by the underlying malignancy, when proteins restricted to immune privileged neurons are presented by the tumour. Previous studies have shown presence of anti-neuronal antibodies in systemic lupus erythematosus and neuropsychiatric lupus (NPSLE) but information on individual antibodies and their pathogenic role is lacking.

View Article and Find Full Text PDF

Changing landscape in the field of paraneoplastic neurology: Personal perspectives over a 35-year career.

Handb Clin Neurol

March 2024

IDIBAPS-Hospital Clinic, University of Barcelona, Barcelona, Spain; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain. Electronic address:

Paraneoplastic neurologic syndromes are a group of rare disorders that have fascinated neurologists for more than a century. The discovery in the 1980s that many of these disorders occurred in association with antibodies against neuronal proteins revived the interest for these diseases. This chapter first traces the history of the paraneoplastic neurologic syndromes during the era that preceded the discovery of immune mechanisms and then reviews the immunologic period during which many of these syndromes were found to be associated with antibodies against intracellular onconeuronal proteins and pathogenic cytotoxic T-cell mechanisms.

View Article and Find Full Text PDF

Retinal Toxicity after Initial Administration of Nivolumab and Ipilimumab.

Case Rep Ophthalmol Med

December 2023

Department of Ophthalmology, University Hospital Ulm, Prittwitzstraße 43, 89075 Ulm, Germany.

Background: To present a rare case of a bilateral immune checkpoint inhibitor- (ICI-) induced photoreceptor injury with a bacillary layer detachment (BALAD) and a dissection of the photoreceptor inner and outer segment, accompanied by ICI-induced Vogt-Koyanagi-Harada- (VKH-) like uveitis after initial administration of nivolumab and ipilimumab. . A 52-year-old female with metastatic malignant cutaneous melanoma experiencing bilateral progressive visual acuity reduction, after treatment initiation with 1 mg/kg nivolumab and 3 mg/kg ipilimumab two weeks prior symptom onset.

View Article and Find Full Text PDF

PSYCHIATRIC DISORDERS IN AUTOIMMUNE ENCEPHALITIS - LITERATURE REVIEW.

Pol Merkur Lekarski

January 2024

DEPARTMENT OF NEUROLOGY, INSTITUTE OF MEDICAL SCIENCES, UNIVERSITY OF OPOLE, OPOLE, POLAND; DEPARTMENT OF NEUROLOGY, ST. JADWIGA REGIONAL SPECIALIZED HOSPITAL, OPOLE, POLAND.

Autoimmune encephalitis (AE) is a non-infectious inflammatory disease caused by the presence of autoantibodies directed against neuronal surface or intracellular antigens. Its incidence in Western countries is about 0.8 per 100,000 people.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!